This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/10/2023
From a planning perspective, we continue to expect consistent performance throughout the remainder of the year. That being said, for us, our focus is making sure that we have a phenomenal clinician experience, not just in how we attract our clinicians here, but how we deliver on that value proposition once they are here. That includes things like we've spoken about before. around frontline support in our administrative staff, additional attention on billing and the service that we're providing, not just to our clinicians, but to the patients and how they interact with our teams, et cetera. So, you know, a lot to still do there, but, you know, we feel good at where we're at today.
Has there been any change to the mix with in-person versus remote, just even in the last three months or six months. I know it was always a little bit higher than what was originally anticipated, and I'm wondering if it's just going to, the anticipation just maintains that level going forward. I think it was 75%, if I'm not mistaken.
Yeah, we continue to see a slow return to in-person as far as our overall mix. In Q1, it was 75% virtual, 25% in-person. That was about a two- to three-point shift back towards in-person versus the previous quarter, and that's been approximately the rate that we've seen it returning to in-person every quarter. So, you know, we fully expect that that trend will continue to We have seen patient demand for in-person increase, as well as, again, our clinicians returning more in-person over time.
You're reading a preview of the LFST Q1 2023 earnings call.
Free account.
